All In MedTech

Device Trial Radar · NCT03111550

Clinical Investigation of the Next-Generation Intraocular Lens

Clinical Investigation of the TECNIS Next-Generation Intraocular Lens

Last checked: Nov 19, 2026Latest source record: Jun 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 242 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

242

Actual

Start

May 10, 2017

Primary completion

Feb 23, 2018

Study completion Feb 23, 2018

Sponsor

Lead sponsor
Abbott Medical OpticsPublic (ABT)
Sponsor type
Industry
First posted
Apr 13, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a 6-month, prospective, multicenter, bilateral, randomized clinical investigation of the TECNIS Model ZHR00 and Model ZQR00 IOLs versus the TECNIS Symfony control IOL. The study was conducted at 12 sites in the U.S.A and treated approximately 240 subjects, equally split between the two test groups and the control group.

Conditions

  • Cataract

Interventions

  • Investigational Intraocular Lens Device #1: TECNIS Model ZHR00Device

    Intraocular lens replaces the natural lens removed during cataract surgery.

  • Investigational Intraocular Lens Device #2: TECNIS Model ZQR00Device

    Intraocular lens replaces the natural lens removed during cataract surgery.

  • TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00Device

    Intraocular lens replaces the natural lens removed during cataract surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Monocular Distance Corrected Near Visual Acuity (DCNVA) at 40 cmTime frame: 1 month postoperative
  2. Rates of Adverse Events vs ISO (International Organization for Standardization) SPE ( Safety and Performance Endpoint) Rates (6-Month Persistent Medical Complications/Adverse Events vs ISO 11979-9 SPE Rates)Time frame: 6 months postoperative
  3. Rates of Adverse Events vs ISO SPE Rates (6-Month Cumulative Medical Complications/Adverse Events vs ISO 11979-9 SPE Rates)Time frame: 6 months postoperative

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Empire Eye and Laser Center

    Bakersfield, California

  • Assil Eye Institute

    Beverly Hills, California

  • Jones Eye Care

    Sioux City, Iowa

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.